What is Oasis Diagnostics?
Oasis Diagnostics Corporation is dedicated to advancing modern medicine by creating non-invasive saliva collection tools and testing devices. Their product suite features standardized saliva collection kits for RNA, DNA, and biomarker collection, serving the life science and research sectors. The company's commitment to cost-effective, non-invasive diagnostic solutions addresses critical needs within the in vitro diagnostics marketplace, including molecular diagnostics and point-of-care testing. Through proprietary and patented technologies, Oasis Diagnostics aims to significantly improve public health and wellness.
How much funding has Oasis Diagnostics raised?
Oasis Diagnostics has raised a total of $733K across 1 funding round:
Grant
$733K
Grant (2013): $733K with participation from National Institutes of Health
Key Investors in Oasis Diagnostics
National Institutes of Health
The National Institutes of Health (NIH) is a primary agency of the U.S. Department of Health and Human Services, responsible for biomedical and health-related research, providing critical backing for scientific advancements.
What's next for Oasis Diagnostics?
With the recent infusion of capital, Oasis Diagnostics is poised for significant expansion and further development of its innovative diagnostic technologies. The company's focus on non-invasive saliva-based testing positions it favorably within the rapidly growing diagnostics market. Future strategic initiatives are likely to involve scaling production, expanding research collaborations, and potentially exploring new clinical applications for their patented collection and testing devices. This backing will enable Oasis Diagnostics to further solidify its market presence and drive advancements in accessible healthcare solutions.
See full Oasis Diagnostics company page
